China Resources Double-Crane Pharmaceutical Co.,Ltd.

Sümbol: 600062.SS

SHH

23.35

CNY

Turuhind täna

17.5971
P/E suhe
-0.5329
PEG suhe
24.20B
MRK Cap
0.01%
DIV tootlus

China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062-SS) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes China Resources Double-Crane Pharmaceutical Co.,Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
balance-sheet.row.cash-and-short-term-investments	3457	2830.7	3637.6	3262.2	2602.1	1975.7	1248.1	1486.9	778.2	1366.3	1410	1004.7	1104.5	1056.6	1023.5	1028.4	654.3	452	668.7	573.7	444.7	513.7	555.3	302.8	318.7	140.7	337.9	9.2	14.3	1.1
balance-sheet.row.short-term-investments	240.7	200.5	803.6	851.9	758.1	878.7	-18	-33.2	-42.6	-31.4	0	0	0	0	0	0	0	0	0.1	0	0	0	0	98.4	0	0	0	0	0	0
balance-sheet.row.net-receivables	2403.5	2362.8	2127	2216.7	2130.9	2017.5	1892.7	1864.7	1737.4	1386.6	1886.8	1969.7	1849.3	1408.8	1239.8	1012.2	1358.8	971.1	1095.3	1209.3	1378.7	1197.8	720.6	44.7	37.8	39.6	86.3	23.4	67.9	76.3
balance-sheet.row.inventory	1562.4	1878.6	1665.5	1289.3	1146	973.6	974.2	762.8	808.7	653.7	566.1	779.1	701	709.9	600.1	604.5	528.6	466.5	507.3	485.2	563.6	584.7	407.4	174.5	141.5	117.3	30.2	36.5	0	1.8
balance-sheet.row.other-current-assets	215.5	92.8	92.5	32	159.7	168.4	665.1	191.4	435	514.4	18.2	138	42.2	18.2	6.2	37.3	-231	-69.9	-137.1	-129.7	-72.7	-115	0.5	294.9	210.2	79.3	-26.2	-8.3	-3.2	-2.9
balance-sheet.row.total-current-assets	7638.5	7165	7522.6	6800.3	6038.7	5135.2	4780.2	4305.8	3759.3	3921.1	3881.2	3891.6	3697	3193.5	2869.6	2682.5	2310.6	1819.6	2134.1	2138.5	2314.2	2181.2	1683.8	816.9	708.3	376.9	428.2	60.8	79	76.3
balance-sheet.row.property-plant-equipment-net	3852.5	3506.6	2957.1	2673	2621.8	2632.5	2449.6	2361.4	2444.2	2053.6	2017.5	2027.8	1827.4	1563.2	1432.5	1223.9	997.8	1274.6	1504.9	1552.1	1538.7	1120.4	912.9	452.4	336.9	236	123.7	93.5	53.3	55
balance-sheet.row.goodwill	906.1	935	788.2	796.4	839.8	864.4	797	391.7	391.7	109.5	109.5	110.3	66.6	9.1	9.1	9.1	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	2482.3	2281	1899.5	1650.7	1637.4	1525.6	1315.8	1031.9	978	385.4	384.7	343	307.9	233.1	201.7	147.8	163.6	52.2	53.3	74.9	78.5	75.9	45.2	60.3	61.6	67.5	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	3388.3	3216	2687.7	2447.1	2477.2	2390	2112.8	1423.6	1369.7	494.9	494.2	453.3	374.5	242.2	210.7	156.9	164.4	52.2	53.3	74.9	78.5	75.9	45.2	60.3	61.6	67.5	0	0	0	0
balance-sheet.row.long-term-investments	403.1	149.8	-500.2	-481.9	-723.9	-855.9	20.1	49.7	64.3	53	0	0	0	0	0	0	0	0	109.6	0	0	0	98.7	40.7	0	0	0	0	0	0
balance-sheet.row.tax-assets	192	124.7	73.8	52.2	50.3	53.5	50.2	42.8	29.2	27.7	29.9	21.7	23.6	27.2	27	24.6	14.3	0	0	0	0	0	5.7	111.5	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	22.1	320.6	935.1	925.7	812.7	951	24.9	58.3	96.5	68.9	58.1	113.5	154.4	179.4	177.1	181.2	186.3	112.9	11.4	259.7	326.4	239	0	2.4	78	60.6	22.8	0	0	0
balance-sheet.row.total-non-current-assets	7858	7317.6	6153.5	5616.2	5238.2	5171	4657.7	3935.8	4003.8	2698.2	2599.7	2616.2	2380	2012.1	1847.4	1586.6	1362.8	1439.7	1679.2	1886.7	1943.6	1435.3	1062.5	667.3	476.6	364.1	146.5	93.5	53.3	55
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	15496.5	14482.5	13676.1	12416.5	11276.9	10306.2	9437.9	8241.5	7763.1	6619.3	6480.9	6507.8	6077	5205.5	4717	4269	3673.5	3259.3	3813.3	4025.3	4257.9	3616.5	2746.3	1484.2	1184.8	741	574.7	154.3	132.3	131.3
balance-sheet.row.account-payables	696.7	744.5	847.4	848	690.8	547.3	469.2	395.7	400.7	488.4	428.5	959.9	718.3	568.3	518.1	440.5	593	624.2	745.1	924.6	1041.8	829.2	499.7	192.8	116.4	33.1	19.6	8.2	11.5	18
balance-sheet.row.short-term-debt	432.9	32.1	29.5	6.6	64.9	75	0	0	30	0	210	295	400.7	279.4	278	341.5	311	318.5	717.8	885.4	875.8	697.9	374.5	249.3	186.6	106	75	31.5	0.4	0
balance-sheet.row.tax-payables	65.7	201.7	138.9	122.6	131.3	153.6	113.9	108.7	121.4	68.2	112.3	62.9	150.7	68.7	55.7	60.9	120.3	65.2	101.4	113.6	94.6	131.3	84.9	69.9	41.2	21.3	2.4	-0.2	0	0
balance-sheet.row.long-term-debt-total	29.9	232.9	35.4	151	0.5	7	1.5	1.5	11.2	1.2	0	0	0	13.4	0	0	16	23	4.1	4.1	204	8.6	52	1	2.3	10	0	4	0	0
Deferred Revenue Non Current	180.6	198.8	153.8	100.9	97.8	113.8	108.2	111.4	132.7	108.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	1822.3	2042.3	57.2	43.9	43.9	1352.2	739.9	619.6	120.4	337.9	89.6	65.9	59.6	52	43.8	29.3	68.8	31.4	55.8	38.1	43.6	49	32.1	18.2	35.7	0.7	0	2.6	3.5	18.4
balance-sheet.row.total-non-current-liabilities	364	741.1	468.6	369.5	258.9	269.6	380.2	187.8	224.9	108.6	115.8	118.7	81.8	89.5	54.1	41.3	52.2	29.9	52.4	65.5	264.7	45.9	106.3	6.7	7.2	11	0	4	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	29.9	32.9	35.4	121.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	3526.1	3752.9	3199.5	3039.5	2600.3	2397.6	1589.3	1203.1	1329.2	934.9	1144.7	1801	1733.7	1279.6	1182.2	1118.6	1308.8	1264.1	1874	2297.9	2541.2	2011.6	1256.3	628.9	473.6	199.6	101.8	48.5	29.2	36.4
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1039.7	1043.2	1043.2	1043.2	1043.2	1043.2	869.4	724.5	724.5	571.7	571.7	571.7	571.7	571.7	571.7	476.4	441.1	441.1	441.1	441.1	441.1	441.1	339.3	305.7	235.2	147	147	88	86.8	86.8
balance-sheet.row.retained-earnings	9670.6	8560.9	8196.4	7580.1	6892.1	6186.8	5517.4	4939.2	4374.9	3643.3	3296.9	2610.9	2216	1867.4	1511.8	1249.4	980.8	527	462.5	326.3	289	244.3	171.4	132.8	71.9	86.5	38	4.5	1.9	1.9
balance-sheet.row.accumulated-other-comprehensive-income-loss	380	594.3	561.9	566.8	563.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	0	-175.7	103.9	103.9	103.9	609.9	1070	1022.5	1007.2	1464.1	1464.1	1471	1470	1424.1	1387.1	1353.7	775.6	847.5	824.3	771	761.7	718.8	772	352.1	385.2	300.5	287.9	13.3	14.4	6.2
balance-sheet.row.total-stockholders-equity	11090.4	10022.6	9905.5	9294.1	8602.5	7839.9	7456.8	6686.2	6106.7	5679.1	5332.7	4653.6	4257.7	3863.2	3470.5	3079.5	2197.5	1815.5	1727.9	1538.4	1491.8	1404.2	1282.8	790.6	692.2	534	472.9	105.8	103.1	94.9
balance-sheet.row.total-liabilities-and-stockholders-equity	15496.5	14482.5	13676.1	12416.5	11276.9	10306.2	9437.9	8241.5	7763.1	6619.3	6480.9	6507.8	6077	5205.5	4717	4269	3673.5	3259.3	3813.3	4025.3	4257.9	3616.5	2746.3	1484.2	1184.8	741	574.7	154.3	132.3	131.3
balance-sheet.row.minority-interest	699.4	707	571.1	82.9	74.1	68.7	391.8	352.3	327.2	5.2	3.5	53.1	85.6	62.8	64.3	70.9	167.2	179.7	211.4	188.9	224.8	200.7	207.2	64.7	19	7.5	0	0	0	0
balance-sheet.row.total-equity	11789.8	10729.6	10476.6	9377	8676.6	7908.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	643.8	350.3	303.4	370.1	34.3	22.8	2.1	16.5	21.7	21.6	26.7	26.7	64.1	85.3	83.4	81.5	82.9	103.4	109.7	252.2	325.6	194.5	98.7	139.1	70.1	53.2	0	0	0	0
balance-sheet.row.total-debt	462.9	265	64.9	6.6	64.9	82	0	0	41.2	1.2	210	295	400.7	292.8	278	341.5	311	318.5	721.9	889.5	1079.7	706.4	426.5	250.3	188.9	116	75	35.5	0.4	0
balance-sheet.row.net-debt	-2753.4	-2365.3	-2769.1	-2403.6	-1779.1	-1015.1	-1248.1	-1486.9	-737	-1365.1	-1200	-709.7	-703.8	-763.8	-745.5	-686.9	-343.3	-133.5	53.3	315.9	635	192.7	-128.8	45.9	-129.9	-24.7	-262.9	26.3	-13.9	-1.1

Rahavoogude aruanne

China Resources Double-Crane Pharmaceutical Co.,Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	1333	1215.4	972.1	1013.5	1066.5	989.5	882.1	739.2	664.8	543.7	873.4	630.5	552.5	533	463.5	396.5	457.6	179.2	190	-25.4	51.6	146.2	162	138.6	75.3	61.1
cash-flows.row.depreciation-and-amortization	655.5	540.6	465	371.7	357.4	343.7	335.8	313.7	269.3	235.6	267.7	214.8	176.4	157.9	135.5	126.4	105.7	99.7	118.3	123.6	101.4	89.6	79.2	43.1	62.6	12.7
cash-flows.row.deferred-income-tax	-18.1	-20.7	-23.8	-3.1	-3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	-1705.5	36	23.8	3.1	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-412.6	-413.5	-143.5	-62.4	-31.3	152.6	-35.3	-276.3	-213.7	-65.7	-368.2	-459.9	-244.8	-202.8	-214.2	-244.3	-197	-119.4	-227.4	103.3	-196.3	-145	-166.8	-26.1	-27.4	-93.2
cash-flows.row.account-receivables	-488.7	-266.2	-130.7	-216.2	-369.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	315.7	-34.3	-384.5	-146.8	-185.1	-4.9	-202.9	31.6	33.5	-85.2	-46.2	-78.1	18.8	-111.8	11.4	-104.9	-64.1	-14.1	-55	75.8	64.8	-58.4	-74.5	-33	-27.9	-87.1
cash-flows.row.account-payables	-221.6	-92.2	395.5	303.6	526.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-18	-20.7	-23.8	-3.1	-3.2	157.5	167.5	-307.9	-247.2	19.5	-321.9	-381.8	-263.6	-91.1	-225.6	-139.4	-133	-105.3	-172.4	27.5	-261.1	-86.6	-92.3	7	0.6	-6.1
cash-flows.row.other-non-cash-items	1798.5	-16.1	47.2	37.3	47.3	-16.8	4.5	-5.4	-19.1	4.7	-226.7	10.5	27.4	21.6	-42.7	53.2	-130.8	144.2	59	252.2	192.3	49.9	66.6	17.2	21.1	5.6
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-604.5	-525.5	-491.7	-348.1	-241.6	-228.7	-154.8	-110	-168.5	-142.4	-217.7	-221.9	-338.8	-370.2	-285.2	-309.2	-136.2	-171.7	-127.1	-196.8	-376	-252	-175.6	-86.8	-69.9	-130.3
cash-flows.row.acquisitions-net	-127.2	-409.2	36.6	42.7	-112.8	-257.7	-648.2	1.2	-697.1	149.4	194	-111.3	-50.3	0	0	0	171.8	41.6	12.8	0	43.5	2.2	4.8	0.2	0	0
cash-flows.row.purchases-of-investments	-2340	-1350	-3199.9	-2421.4	-3064.1	-2019.7	-1290.8	-735	-2607.5	-1280	-2.9	-4.6	-76.5	0	6.8	0	-24.1	-10.8	-15.7	0	-152.7	-55.7	-59.4	-169.3	-30	-26.8
cash-flows.row.sales-maturities-of-investments	2303	2951.7	3051.7	2296	2342.7	1678.7	864.9	1003	2723.7	898.6	119	94.9	55.8	0	2.8	1.2	2	45.4	261.6	11.7	4.5	2.1	103.7	5.7	1	0
cash-flows.row.other-investing-activites	60.9	-0.2	33.4	12.9	6.5	4	96.4	4.2	39.2	22	6.4	34.6	5.7	62.4	43.9	138.1	13	7.7	-21.9	32.7	7.8	-1.3	53.2	-2	0	12.9
cash-flows.row.net-cash-used-for-investing-activites	-707.8	666.8	-569.8	-418	-1069.3	-823.5	-1132.5	163.3	-710.1	-352.3	98.9	-208.3	-404.2	-307.8	-231.6	-170	26.6	-87.9	109.7	-152.4	-472.9	-304.7	-73.3	-252.2	-98.8	-144.2
cash-flows.row.debt-repayment	-9.3	-6.2	-47.7	-64.3	-306.9	-36.6	0	-40	-182.9	-210	-265	-694.8	-595.3	-283.8	-470.8	-350.3	-314.5	-689.3	-895.3	-983.1	-1113.8	-635.7	-576.7	-358.5	-224.9	-173.6
cash-flows.row.common-stock-issued	-29.7	144.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	-1	-290.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-300.5	-801.8	-302.6	-319.3	-299.2	-91.1	-193.7	-184.7	-3.4	-199.7	-217.2	-250.8	-155	-145.7	-79.9	-111.3	-93.2	-106.4	-43.9	-48.1	-89.1	-68	-56.2	-41.6	0	-8.9
cash-flows.row.other-financing-activites	-17.8	-337	-28.3	-2.5	81.2	-675.4	-99.7	0	-397.7	0	371.5	613.4	694.5	275.5	386.4	723.7	304.6	392.3	775.9	858.8	1457.9	826.1	915.9	365.2	370.2	143.2
cash-flows.row.net-cash-used-provided-by-financing-activities	-358.3	-1291.2	-378.6	-386.2	-524.9	-803.1	-293.5	-224.7	-583.9	-409.7	-110.7	-332.3	-55.8	-154	-164.3	262.2	-103.1	-403.4	-163.3	-172.4	255	122.4	283.1	-34.9	145.3	-39.3
cash-flows.row.effect-of-forex-changes-on-cash	3.7	12.3	1.3	-0.1	0	0	-0.1	0	0.1	0	-0.4	-0.1	0.8	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	585.8	729.6	393.8	555.9	-154.4	-157.5	-238.9	709.9	-592.5	-43.7	534	-144.5	52.3	47.9	-53.9	423.9	159.1	-187.1	86.1	129	-69	-41.6	350.8	-114.3	178.1	-197.2
cash-flows.row.cash-at-end-of-period	3216.3	2614.7	1885.1	1491.3	935.4	1089.8	1247.3	1486.2	776.3	1366.3	1410	876	1020.6	968.2	920.3	974.2	550.3	375	562.1	573.7	444.7	513.7	555.3	204.5	318.7	140.7
cash-flows.row.cash-at-beginning-of-period	2630.4	1885.1	1491.3	935.4	1089.8	1247.3	1486.2	776.3	1368.8	1410	876	1020.6	968.3	920.3	974.2	550.3	391.2	562.1	476	444.7	513.7	555.3	204.5	318.7	140.7	337.9
cash-flows.row.operating-cash-flow	1650.8	1341.7	1340.9	1360.2	1439.8	1469	1187.1	771.2	701.3	718.4	546.2	396	511.5	509.7	342	331.7	235.5	303.7	139.8	453.7	148.9	140.6	141	172.8	131.5	-13.8
cash-flows.row.capital-expenditure	-604.5	-525.5	-491.7	-348.1	-241.6	-228.7	-154.8	-110	-168.5	-142.4	-217.7	-221.9	-338.8	-370.2	-285.2	-309.2	-136.2	-171.7	-127.1	-196.8	-376	-252	-175.6	-86.8	-69.9	-130.3
cash-flows.row.free-cash-flow	1046.3	816.1	849.2	1012.1	1198.1	1240.3	1032.3	661.2	532.9	576	328.6	174.2	172.7	139.5	56.9	22.5	99.3	132.1	12.6	256.9	-227	-111.4	-34.6	86	61.7	-144.1

Kasumiaruande rida

China Resources Double-Crane Pharmaceutical Co.,Ltd. tulud muutusid võrreldes eelmise perioodiga NaN%. 600062.SS brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
income-statement-row.row.total-revenue	10089.3	9446.9	9111.5	8503.9	9381	8225.1	6421.8	5494.8	5138.4	4281	6834.6	6989.3	6383.4	5366.8	5037.9	4951.5	4556.6	4049.1	4597.4	4195.7	4249.2	3686.3	2382.7	1168.3	723.2	350.7	236.3	208.4	168.1	156.7
income-statement-row.row.cost-of-revenue	4948.2	4231.8	4030	3145.2	3430.6	3014.4	2733.7	2576.5	2473.1	2206	4470	4661.5	4321.5	3424.9	3327.6	3417.7	3186.3	2902.8	3365.2	3085.9	3096.8	2544.8	1500.4	634	447.5	227.2	160.9	131.1	103.4	107
income-statement-row.row.gross-profit	5141.2	5215.1	5081.5	5358.7	5950.3	5210.7	3688.1	2918.3	2665.3	2075	2364.6	2327.9	2061.9	1941.9	1710.4	1533.8	1370.4	1146.3	1232.3	1109.8	1152.4	1141.5	882.2	534.4	275.6	123.4	75.4	77.3	64.7	49.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-14.5	639.7	612.8	682.9	589.3	-5.2	-6.4	69.3	49.5	27.5	33.3	33	62.5	31.4	22.9	18.6	180.9	48.6	-16.2	12.1	20.3	21.1	19.8	11.3	16.5	12.6	4.4	0	0	0.6
income-statement-row.row.operating-expenses	3684.5	3901.5	3978.5	4121.8	4645.2	4031.3	2612.3	2060.8	1918.6	1453.1	1561.8	1613.5	1412.5	1335.3	1163.9	1071.9	913.5	920.4	1017.2	996.7	972.3	932.6	684.3	355.9	173.9	54.6	27.6	23.7	16.7	14.1
income-statement-row.row.cost-and-expenses	8632.6	8133.4	8008.5	7267	8075.8	7045.7	5346.1	4637.3	4391.8	3659	6031.7	6275	5734	4760.2	4491.5	4489.6	4099.7	3823.1	4382.3	4082.6	4069.1	3477.4	2184.7	989.9	621.4	281.8	188.5	154.8	120.1	14.1
income-statement-row.row.interest-income	52.9	88.5	54.4	48.5	20.3	12	10.9	9.7	26.8	24.4	16.8	12.8	12.2	5.8	5.1	0	0	7.7	15	4.8	5.3	9	3.8	3	0	0	0	0	0	0
income-statement-row.row.interest-expense	15.4	10.6	11.6	3.7	9.5	8.2	0	2.4	6.5	4.7	22.5	24.2	23.5	12.5	14.5	12.8	11.4	27	49.4	46.8	48.4	37.3	28.2	18.1	12	-3.5	-0.8	3	3.8	3.9
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	97.3	8.5	-15.8	-14.2	-0.7	4.8	-21.8	49.3	60.1	36.5	263.9	48.4	53.6	10.3	15	8.8	117.8	9.5	12.4	-99.2	-104.7	-27	-20	-6	-2.2	14.5	5.1	-3	-3.8	-3.9
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-14.5	639.7	612.8	682.9	589.3	-5.2	-6.4	69.3	49.5	27.5	33.3	33	62.5	31.4	22.9	18.6	180.9	48.6	-16.2	12.1	20.3	21.1	19.8	11.3	16.5	12.6	4.4	0	0	0.6
income-statement-row.row.total-operating-expenses	97.3	8.5	-15.8	-14.2	-0.7	4.8	-21.8	49.3	60.1	36.5	263.9	48.4	53.6	10.3	15	8.8	117.8	9.5	12.4	-99.2	-104.7	-27	-20	-6	-2.2	14.5	5.1	-3	-3.8	-3.9
income-statement-row.row.interest-expense	15.4	10.6	11.6	3.7	9.5	8.2	0	2.4	6.5	4.7	22.5	24.2	23.5	12.5	14.5	12.8	11.4	27	49.4	46.8	48.4	37.3	28.2	18.1	12	-3.5	-0.8	3	3.8	3.9
income-statement-row.row.depreciation-and-amortization	655.5	582.3	491	444.5	427.3	343.7	335.8	313.7	269.3	235.6	267.7	214.8	176.4	157.9	135.5	126.4	105.7	99.7	118.3	123.6	101.4	89.6	79.2	43.1	62.6	12.7	-1	3	3.8	-45.8
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	1456.7	1406.1	1136.9	1229.3	1262.5	1189.3	1060.4	843.2	764.3	638.4	1033.9	731.3	655.2	592.7	542.2	452	393.8	222.1	270	29.9	116.7	208.2	189	175.1	93.2	73.5	48.9	50.7	44.2	31.7
income-statement-row.row.income-before-tax	1554	1414.6	1121.2	1215	1261.8	1184.1	1053.9	906.8	806.8	658.4	1066.8	762.8	703	616.9	561.4	470.7	574.7	253.1	240.7	28	106.2	205.6	193.4	179.4	104.6	84.7	53.1	50.7	44.2	31.7
income-statement-row.row.income-tax-expense	240.6	199.3	149.1	201.5	195.3	194.7	171.8	167.5	141.9	114.7	193.3	132.2	150.5	83.9	98	74.2	117.1	67.5	51.9	53.4	54.7	59.4	31.3	40.8	29.4	23.6	5.5	-3	0.2	0.2
income-statement-row.row.net-income	1333	1180.1	935.7	1005.2	1055.1	968.6	842.6	714.2	661.1	541.9	870.7	614.4	529	520.1	451.5	380.6	437.6	164.9	186.6	4.7	64.6	168.4	157.7	128.9	75.9	60.9	47.5	50.7	44	31.5